These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15537567)

  • 21. Burkholderia cepacia complex: impact on the cystic fibrosis lung lesion.
    Lynch JP
    Semin Respir Crit Care Med; 2009 Oct; 30(5):596-610. PubMed ID: 19760547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of the E test to assess synergy of antibiotic combinations against isolates of Burkholderia cepacia-complex from patients with cystic fibrosis.
    Manno G; Ugolotti E; Belli ML; Fenu ML; Romano L; Cruciani M
    Eur J Clin Microbiol Infect Dis; 2003 Jan; 22(1):28-34. PubMed ID: 12582741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria.
    Hadjiliadis D; Steele MP; Chaparro C; Singer LG; Waddell TK; Hutcheon MA; Davis RD; Tullis DE; Palmer SM; Keshavjee S
    J Heart Lung Transplant; 2007 Aug; 26(8):834-8. PubMed ID: 17692788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meropenem administered as a prolonged infusion to treat serious gram-negative central nervous system infections.
    Capitano B; Nicolau DP; Potoski BA; Byers KE; Horowitz M; Venkataramanan R; Paterson DL
    Pharmacotherapy; 2004 Jun; 24(6):803-7. PubMed ID: 15222672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steady-state pharmacokinetics and pharmacodynamics of meropenem in hospitalized patients.
    Cheatham SC; Kays MB; Smith DW; Wack MF; Sowinski KM
    Pharmacotherapy; 2008 Jun; 28(6):691-8. PubMed ID: 18503396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Burkholderia cepacia complex infection in adult patients with cystic fibrosis--is early eradication possible?
    Etherington C; Peckham DG; Conway SP; Denton M
    J Cyst Fibros; 2003 Dec; 2(4):220-1. PubMed ID: 15463878
    [No Abstract]   [Full Text] [Related]  

  • 27. Burkholderia cepacia infections in cystic fibrosis.
    Burns JL; Saiman L
    Pediatr Infect Dis J; 1999 Feb; 18(2):155-6. PubMed ID: 10048690
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy and safety of intravenous meropenem and tobramycin versus ceftazidime and tobramycin in cystic fibrosis.
    Latzin P; Fehling M; Bauernfeind A; Reinhardt D; Kappler M; Griese M
    J Cyst Fibros; 2008 Mar; 7(2):142-6. PubMed ID: 17766190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystic fibrosis infections: treatment strategies and prospects.
    George AM; Jones PM; Middleton PG
    FEMS Microbiol Lett; 2009 Nov; 300(2):153-64. PubMed ID: 19674113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and pharmacodynamics of meropenem in febrile neutropenic patients with bacteremia.
    Ariano RE; Nyhlén A; Donnelly JP; Sitar DS; Harding GK; Zelenitsky SA
    Ann Pharmacother; 2005 Jan; 39(1):32-8. PubMed ID: 15598967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Refractory
    Lim BA; Lopez A; Buensalido JA
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31377717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcomes and cost minimization with an alternative dosing regimen for meropenem in a community hospital.
    Patel GW; Duquaine SM; McKinnon PS
    Pharmacotherapy; 2007 Dec; 27(12):1637-43. PubMed ID: 18041884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Isolation and identification of Burkholderia cepacia complex from cystic fibrosis patients].
    Yurdakul P; Ergünay K; Yalçin E; Doğru D; Sener B; Cobanoğlu N; Ozçelik U; Kiper N
    Mikrobiyol Bul; 2006 Oct; 40(4):301-6. PubMed ID: 17205687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuralgic amyotrophy associated with antibiotic therapy.
    Finstad K; Guajardo JR; Scoville C
    Ann Pharmacother; 2008 Sep; 42(9):1344-7. PubMed ID: 18682542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mediastinal abscess after lung transplantation secondary to Burkholderia gladioli infection.
    Church AC; Sivasothy P; Parmer J; Foweraker J
    J Heart Lung Transplant; 2009 May; 28(5):511-4. PubMed ID: 19416783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meropenem time above the MIC exposure is predictive of response in cystic fibrosis children with acute pulmonary exacerbations.
    Kuti JL; Pettit RS; Neu N; Cies JJ; Lapin C; Muhlebach MS; Novak KJ; Nguyen ST; Saiman L; Nicolau DP
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):294-297. PubMed ID: 29661528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic resistance in Burkholderia cepacia at two regional cystic fibrosis centres in Northern Ireland: is there a need for synergy testing?
    Moore JE; Crowe M; Shaw A; McCaughan J; Redmond AO; Elborn JS
    J Antimicrob Chemother; 2001 Aug; 48(2):319-21. PubMed ID: 11481312
    [No Abstract]   [Full Text] [Related]  

  • 38. Burkholderia cepacia complex infection in a case of sinonasal polyposis recurrence without cystic fibrosis.
    Brescia G; Pavin A; Rinaldi R; Marioni G; Staffieri A
    Auris Nasus Larynx; 2008 Sep; 35(3):414-6. PubMed ID: 17913420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of high-dose extended-infusion meropenem during pulmonary exacerbation in adult cystic fibrosis patients: a case series.
    Delfino E; Fucile C; Del Bono V; Marchese A; Marini V; Coppo E; Casciaro R; Minicucci L; Giacobbe DR; Martelli A; Viscoli C; Mattioli F
    New Microbiol; 2018 Jan; 41(1):47-51. PubMed ID: 29313863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Arthritis caused by Burkholderia cepacia].
    Rodríguez MS; de la Fuente J; Montero J; Rodríguez MI
    Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):258-9. PubMed ID: 19783076
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.